Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Cerilliant
Fish and Richardson
Boehringer Ingelheim
Dow
Healthtrust
Colorcon
Teva
Fuji

Generated: August 18, 2017

DrugPatentWatch Database Preview

ADRUCIL Drug Profile

« Back to Dashboard

Which patents cover Adrucil, and when can generic versions of Adrucil launch?

Adrucil is a drug marketed by Pharmacia And Upjohn and Teva Parenteral and is included in four NDAs.

The generic ingredient in ADRUCIL is fluorouracil. There are fifteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the fluorouracil profile page.

Summary for Tradename: ADRUCIL

Patents:0
Applicants:2
NDAs:4
Bulk Api Vendors: see list124
Clinical Trials: see list31
Patent Applications: see list169
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ADRUCIL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
ADRUCIL
fluorouracil
INJECTABLE;INJECTION081222-001Jun 28, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
ADRUCIL
fluorouracil
INJECTABLE;INJECTION017959-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
ADRUCIL
fluorouracil
INJECTABLE;INJECTION040023-001Oct 18, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
ADRUCIL
fluorouracil
INJECTABLE;INJECTION081225-001Aug 28, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Teva
Mallinckrodt
Colorcon
Cerilliant
Fish and Richardson
Argus Health
Novartis
Accenture
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot